This inventor holds 1 USPTO granted patent. Top assignee: Oregon State University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Paul R Blakemore: Innovator in Medicinal Chemistry
Introduction
Paul R Blakemore is a notable inventor based in Corvallis, Oregon. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on xanthohumol derivatives. His research focuses on the medicinal benefits of these compounds, which have shown promise in improving glucose tolerance and promoting weight management.
Latest Patents
Paul R Blakemore holds a patent for "Xanthohumol derivatives and methods for making and using." This patent includes representative xanthohumol derivatives that have been tested in vivo in mice. The derivatives exhibit important medicinal benefits, such as improving glucose tolerance and decreasing weight gain by increasing energy expenditure and locomotor activity in treated subjects. Additionally, the disclosed derivatives may function as mitochondrial uncouplers. Notable compounds from his patent include 4-(5-(4-hydroxyphenyl)-1-methyl-1H-pyrazol-3-yl)-5-methoxy-2-(3-methylbut-2-en-1-yl)benzene-1,3-diol and 4-(5-(4-hydroxyphenyl)isoxazole-3-yl)-5-methoxy-2-(3-methylbut-2-en-1-yl)benzene-1,3-diol.
Career Highlights
Paul R Blakemore is affiliated with Oregon State University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential applications in medicine and health.
Collaborations
Some of his notable coworkers include Luce M Mattio and Ines L Paraiso. Their collaborative efforts have further advanced the research in the field of medicinal chemistry.
Conclusion
Paul R Blakemore's innovative work on xanthohumol derivatives highlights his significant contributions to medicinal chemistry. His research not only opens new avenues for therapeutic applications but also showcases the importance of collaboration in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
